[MYGN] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 528.68%
YoY- 6,858.33%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 145,200 186,300 202,300 190,200 177,500 183,500 168,837 -2.48%
PBT -43,700 -22,300 800 86,600 4,000 43,500 25,877 -
Tax -28,500 -1,700 1,600 5,600 5,200 16,900 9,895 -
NP -15,200 -20,600 -700 81,100 -1,200 26,600 15,982 -
Tax Rate - - -200.00% -6.47% -130.00% -38.85% -38.24% -
Total Cost 160,400 206,900 203,000 109,100 178,700 156,900 152,855 0.80%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -10.47 -11.06 -0.35 42.64 -0.68 14.50 9.47 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.20 -0.28 -0.01 1.18 -0.02 0.39 0.22 -
EPS Diluted -0.20 -0.28 -0.01 1.15 -0.02 0.37 0.21 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.